Assessment of Vasopressin effect on reduction of bleeding

Not Applicable

• Conditions: Vasopressin.; Other and unspecified hormone antagonists

• Registration Number: IRCT201108173773N4
• Lead Sponsor: Tehran University of Medical Sciences and Health Services

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

A.S.A class 1&2, Age: 20-80, undergoing Total Hip Arthroplasty under Regional Anesthesia
Exclusion criteria: Bleeding disorders, Previous Total Hip Arthroplasty

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Transfusion. Timepoint: during operation. Method of measurement: Nomber of Blood package.

Secondary Outcome Measures

Name	Time	Method
Hemoglobin. Timepoint: After operation. Method of measurement: Labratory instrument (scale g/dL).;Platelet. Timepoint: After operation. Method of measurement: Labratory instrument.;Prothrombin time = Pt. Timepoint: After operation. Method of measurement: Labratory instrument.;Partial thromboplastin time = Ptt. Timepoint: After operation. Method of measurement: Labratory instrument.;International Normalized Ratio = INR. Timepoint: After operation. Method of measurement: Labratory instrument.